Two Sigma Investments’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,200
Closed -$518K 2635
2021
Q4
$518K Sell
3,200
-2,700
-46% -$434K ﹤0.01% 3220
2021
Q3
$880K Buy
5,900
+4,900
+490% +$1.02M ﹤0.01% 2722
2021
Q2
$245K Buy
+1,000
New +$262K ﹤0.01% 3643
2021
Q1
Sell
-2,200
Closed -$645K 3776
2020
Q4
$645K Buy
+2,200
New +$564K ﹤0.01% 2323
2019
Q4
Sell
-2,000
Closed -$262K 3613
2019
Q3
$262K Sell
2,000
-2,400
-55% -$312K ﹤0.01% 3038
2019
Q2
$534K Buy
+4,400
New +$522K ﹤0.01% 2452

Other funds holding AMED

Two Sigma Investments's AMED Position: Q2 2024 in Review

Two Sigma Investments sold out of Amedisys (AMED) in Q2 2024, closing a stake of 6,300 shares — an estimated $581K sold.

Two Sigma Investments first reported a position in AMED in Q2 2013 and held it in 33 quarters. The position peaked at $25.1M in Q3 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Two Sigma Investments reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 6,300 Amedisys shares in Q2 2024, an estimated $581K.
  • Two Sigma Investments first reported a position in Amedisys in Q2 2013 and held it in 33 quarters.
  • Two Sigma Investments's Amedisys position peaked at $25.1M in Q3 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.